Seeing Is Believing

Currently out of the existing stock ratings of Elemer Piros, 208 are a BUY (88.14%), 16 are a HOLD (6.78%), 12 are a SELL (5.08%).
Analyst Elemer Piros, currently employed at LUCID CAPITAL, carries an average stock price target met ratio of 44.22% that have a potential upside of 226% achieved within 277 days. Previously, Elemer Piros worked at ROTH MKM, CANTOR FITZGERALD, BENCHMARK.
Elemer Piros’s has documented 461 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on INMB, INmune Bio at 11-Mar-2026.
Analyst best performing recommendations are on FBRX (FORTE BIOSCIENCES).
The best stock recommendation documented was for FBRX (FORTE BIOSCIENCES) at 4/25/2019. The price target of $28 was fulfilled within 491 days with a profit of $27.63 (7467.57%) receiving and performance score of 152.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Aug-2022
$30
$24.97 (496.42%)
$18
16 days ago
(18-Sep-2026)
0/5 (0%)
$24.43 (438.60%)
Buy Since 16-Oct-2017
$20
$14.39 (256.51%)
$20
4 months 6 days ago
(28-May-2026)
0/13 (0%)
$14.22 (246.02%)
Buy Since 29-Apr-2025
$19
$13.39 (238.68%)
$20
10 months 22 days ago
(12-Nov-2025)
0/3 (0%)
$14.06 (284.62%)
Buy Since 02-Jun-2025
$20
$14.39 (256.51%)
$19
1 years 1 months 19 days ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy Since 30-May-2024
$20
$15.55 (349.44%)
$21
1 years 4 months 18 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
What Year was the first public recommendation made by Elemer Piros?